Eva Zsigmond

888 citations
21 papers · 675 indexed · h-index 12

Eva Zsigmond

20 papers receiving 657 citations

Peers

Eva Zsigmond
Comparison fields: 5 of 101
  • Molecular Biology 277
  • Genetics 42
  • Endocrinology, Diabetes and Metabolism 64
  • Surgery 165
  • Cancer Research 56
Replace Rie Irie with:
Rie Irie Japan
Hong Yue United States
I. Tovar Spain
Yanjia Chen China
Jacob Riehm United States
Brian Estevez United States
Narcissus Teoh Australia
Hideki Ohnishi Japan
Anup Srivastava United States
Xuan Zheng China
Eva Zsigmond relative to Rie Irie Japan Rie Irie's profile →
Citations per field
00.5×1.5×2.3×
Rie Irie · 1×
Citations per year

Countries citing papers authored by Eva Zsigmond

Since Specialization
Citations

This map shows the geographic impact of Eva Zsigmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Zsigmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Zsigmond more than expected).

Fields of papers citing papers by Eva Zsigmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Zsigmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Zsigmond. The network helps show where Eva Zsigmond may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eva Zsigmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Zsigmond Line = papers co-authored together Eva Zsigmond links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202312
2 202212
3 202080
4 20195
5 20190
6 20196
7 20165
8 20148
9 201115
10
The restoration in vivo of 2,3-diphosphoglycerate (2,3-DPG) in stored red cells, after transfusion. The levels of red cells 2,3-DPG.
200911
11 2007170
12 199936
13 199922
14 199815
15 199740
16 19963
17 19964
18 199680
19 1996133
20 19888

About Eva Zsigmond

Eva Zsigmond is a scholar working on Clinical Biochemistry, Ophthalmology and Genetics, having authored 21 papers that have together received 675 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Retinal Development and Disorders (3 papers), Diabetes and associated disorders (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Retinal Diseases and Treatments (2 papers), CRISPR and Genetic Engineering (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Molecular Biology (277 citations), Genetics (42 citations) and Endocrinology, Diabetes and Metabolism (64 citations). Eva Zsigmond has collaborated with scholars based in United States, Canada and Jordan. Frequent co-authors include Rick A. Wetsel, Dachun Wang, Alan R. Burns, David L. Haviland, Louis C. Smith, Martha P. Mims, Lawrence Chan, Kunihisa Kobayashi, Lawrence Chan and Lawrence Chan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026